Ubs Group Ag Ionis Pharmaceuticals Inc Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 1,529,323 shares of IONS stock, worth $63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,529,323
Previous 1,890,602
19.11%
Holding current value
$63 Million
Previous $57 Million
5.93%
% of portfolio
0.01%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding IONS
# of Institutions
406Shares Held
148MCall Options Held
872KPut Options Held
432K-
Vanguard Group Inc Valley Forge, PA16.7MShares$688 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$661 Million0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$516 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$425 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$323 Million5.5% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.85B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...